ArticleCancer immunology, immunotherapy : CII2022

Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.

Hiroaki Wakiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.